Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter.
作者信息
Shah Sanjiv J
机构信息
Division of Cardiology, Department of Medicine, and the Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
出版信息
J Am Coll Cardiol. 2013 Oct 8;62(15):1339-42. doi: 10.1016/j.jacc.2013.07.010. Epub 2013 Jul 31.
Abstract
摘要
相似文献
1
Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter.射血分数保留的心力衰竭临床试验优化的匹配工作：绝非儿戏。
J Am Coll Cardiol. 2013 Oct 8;62(15):1339-42. doi: 10.1016/j.jacc.2013.07.010. Epub 2013 Jul 31.
2
Effect of ivabradine on heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014 Feb 18;63(6):608-9. doi: 10.1016/j.jacc.2013.09.064. Epub 2013 Nov 21.
3
Reply: Effect of ivabradine on heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2014 Feb 18;63(6):609. doi: 10.1016/j.jacc.2013.10.047. Epub 2013 Nov 21.
4
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.If 通道抑制对射血分数保留的心力衰竭患者血流动力学状态和运动耐量的影响：一项随机试验。
J Am Coll Cardiol. 2013 Oct 8;62(15):1330-8. doi: 10.1016/j.jacc.2013.06.043. Epub 2013 Jul 31.
5
Heart rate reduction in heart failure: ivabradine or beta blockers?心力衰竭患者的心率降低：伊伐布雷定还是β受体阻滞剂？
Heart Fail Rev. 2013 Jul;18(4):517-28. doi: 10.1007/s10741-012-9347-6.
6
Ivabradine: Current and Future Treatment of Heart Failure.伊伐布雷定：心力衰竭的当前及未来治疗方法
Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):89-97. doi: 10.1111/bcpt.12784. Epub 2017 May 10.
7
Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.伊伐布雷定：用于左心室射血分数降低的慢性心力衰竭成人患者。
Am J Cardiovasc Drugs. 2012 Dec 1;12(6):415-26. doi: 10.2165/11209990-000000000-00000.
8
Ivabradine in heart failure: hope or hype?伊伐布雷定用于心力衰竭：希望还是炒作？
Am J Cardiovasc Drugs. 2012 Dec 1;12(6):357-9. doi: 10.1007/BF03262470.
9
Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.通过 I(f)-通道抑制来降低心率及其在射血分数降低和保留的心衰中的潜在作用。
Trends Cardiovasc Med. 2009 Jul;19(5):152-7. doi: 10.1016/j.tcm.2009.09.002.
10
Ivabradine might improve exercise capacity in dilated cardiomyopathy in comparison with bisoprolol: assessment with the ergospirometry test.
Rev Esp Cardiol (Engl Ed). 2014 May;67(5):413-4. doi: 10.1016/j.rec.2013.11.019. Epub 2014 Mar 22.
引用本文的文献
1
Echocardiographic Endophenotypes of Chronic Obstructive Pulmonary Disease: A Step toward Personalized Medicine.慢性阻塞性肺疾病的超声心动图内表型：迈向个性化医疗的一步。
Am J Respir Crit Care Med. 2025 Mar;211(3):426-427. doi: 10.1164/rccm.202412-2461ED.
2
Understanding heterogeneous mechanisms of heart failure with preserved ejection fraction through cardiorenal mathematical modeling.通过心肾数学建模理解射血分数保留型心力衰竭的异质性机制。
PLoS Comput Biol. 2023 Nov 13;19(11):e1011598. doi: 10.1371/journal.pcbi.1011598. eCollection 2023 Nov.
3
Heart Failure With Preserved Ejection Fraction: An Evolving Understanding.射血分数保留的心力衰竭：不断发展的认识
Cureus. 2023 Sep 28;15(9):e46152. doi: 10.7759/cureus.46152. eCollection 2023 Sep.
4
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.阐述射血分数保留的心力衰竭中肺动脉高压的临床意义和病理生理学：行动呼吁：美国心脏协会的科学声明。
Circulation. 2022 Aug 16;146(7):e73-e88. doi: 10.1161/CIR.0000000000001079. Epub 2022 Jul 11.
5
Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening.运动诱发的射血分数保留型心力衰竭中的 B 线与舒张功能恶化同时出现。
ESC Heart Fail. 2021 Dec;8(6):5068-5080. doi: 10.1002/ehf2.13575. Epub 2021 Oct 16.
6
Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction.心血管磁共振预测射血分数保留的心力衰竭相关肺动脉高压的全因死亡率。
Int J Cardiovasc Imaging. 2021 Oct;37(10):3019-3025. doi: 10.1007/s10554-021-02279-z. Epub 2021 May 12.
7
Different Pathophysiology and Outcomes of Heart Failure With Preserved Ejection Fraction Stratified by K-Means Clustering.通过K均值聚类分层的射血分数保留的心力衰竭的不同病理生理学及结局
Front Cardiovasc Med. 2020 Nov 30;7:607760. doi: 10.3389/fcvm.2020.607760. eCollection 2020.
8
Bariatric Surgery and Hospitalization for Heart Failure in Morbidly Obese Patients.肥胖症患者的减重手术与心力衰竭住院治疗。
Obes Surg. 2020 Nov;30(11):4218-4225. doi: 10.1007/s11695-020-04787-8. Epub 2020 Jul 2.
9
20th Annual Feigenbaum Lecture: Echocardiography for Precision Medicine-Digital Biopsy to Deconstruct Biology.第 20 届费根鲍姆讲座：精准医学超声心动图——数字活检解构生物学
J Am Soc Echocardiogr. 2019 Nov;32(11):1379-1395.e2. doi: 10.1016/j.echo.2019.08.002.
10
Prominent 'Y' descent is an ominous sign of a poorer prognosis in heart failure with preserved ejection fraction.显著的“Y”型下壁导联改变是射血分数保留的心力衰竭患者预后不良的一个危险信号。
ESC Heart Fail. 2019 Aug;6(4):799-808. doi: 10.1002/ehf2.12460. Epub 2019 May 20.
本文引用的文献
1
Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction.射血分数保留的心力衰竭患者II期研究的评估框架。
JACC Heart Fail. 2013 Apr;1(2):123-6. doi: 10.1016/j.jchf.2013.01.001. Epub 2013 Apr 1.
2
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.If 通道抑制对射血分数保留的心力衰竭患者血流动力学状态和运动耐量的影响：一项随机试验。
J Am Coll Cardiol. 2013 Oct 8;62(15):1330-8. doi: 10.1016/j.jacc.2013.06.043. Epub 2013 Jul 31.
3
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.磷酸二酯酶-5 抑制剂对射血分数保留心力衰竭患者运动能力和临床状态的影响：一项随机临床试验。
JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.
4
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.螺内酯对射血分数保留的心力衰竭患者舒张功能和运动能力的影响：Aldo-DHF 随机对照试验。
JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
5
Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.醛固酮拮抗剂治疗保留心功能心力衰竭患者的基线特征。
Circ Heart Fail. 2013 Mar;6(2):184-92. doi: 10.1161/CIRCHEARTFAILURE.112.972794. Epub 2012 Dec 20.
6
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).卡维地洛对射血分数保留型心力衰竭的影响：日本舒张性心力衰竭研究（J-DHF）。
Eur J Heart Fail. 2013 Jan;15(1):110-8. doi: 10.1093/eurjhf/hfs141. Epub 2012 Sep 14.
7
The many faces of heart failure with preserved ejection fraction.射血分数保留的心力衰竭的多面性。
Nat Rev Cardiol. 2012 Oct;9(10):555-6. doi: 10.1038/nrcardio.2012.123. Epub 2012 Sep 4.
8
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.血管紧张素受体脑啡肽酶抑制剂 LCZ696 治疗射血分数保留的心力衰竭的 II 期双盲随机对照试验。
Lancet. 2012 Oct 20;380(9851):1387-95. doi: 10.1016/S0140-6736(12)61227-6. Epub 2012 Aug 26.
9
Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.If 抑制降低心率可改善射血分数保留心力衰竭小鼠模型的血管僵硬和左心室收缩及舒张功能。
Eur Heart J. 2013 Sep;34(36):2839-49. doi: 10.1093/eurheartj/ehs218. Epub 2012 Jul 24.
10
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.心力衰竭伴左心室射血分数保留患者住院趋势：患病率、治疗方法和结局。
Circulation. 2012 Jul 3;126(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.080770. Epub 2012 May 21.
Zotero 插件